A detailed history of Step Stone Group LP transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Step Stone Group LP holds 422,085 shares of PHAT stock, worth $3.17 Million. This represents 3.12% of its overall portfolio holdings.

Number of Shares
422,085
Previous 422,085 -0.0%
Holding current value
$3.17 Million
Previous $4.35 Million 75.55%
% of portfolio
3.12%
Previous 0.99%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$30.69 - $36.83 $13 Million - $15.5 Million
422,085 New
422,085 $13.5 Million

Others Institutions Holding PHAT

About Phathom Pharmaceuticals, Inc.


  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $294M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Step Stone Group LP Portfolio

Follow Step Stone Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Step Stone Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Step Stone Group LP with notifications on news.